Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT07197970RecruitingPhase 3
Stent for blocked brain arteries
This trial tests whether a drug-coated stent can help people with severely narrowed brain arteries that have already caused a stroke or mini-stroke. It aims to improve blood flow and prevent future strokes.
Beijing, Beijing MunicipalityAges 18–80 - NCT02961413Recruiting
Study of drug-related liver injury in China
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
ShanghaiAges Any age - NCT07100054Enrolling by invitation
Genetic markers for CDK4/6 inhibitor therapy in breast cancer
This trial looks at how genetic markers and other substances in your blood might help personalize treatment with CDK4/6 inhibitors, a targeted therapy for breast cancer. It aims to find better ways to predict which patients will benefit most.
London, OntarioAges 18 years+ - NCT07082192RecruitingPhase 2/Phase 3
Testing CB03-154 for adults with ALS
This trial tests a new medicine, CB03-154, to see if it can help people with ALS. Researchers are comparing different doses to find the safest and most effective one.
Beijing, Beijing MunicipalityAges 18–65 - NCT06980870RecruitingPhase 2
Pain medicine before root canal for less discomfort
This study tests whether taking ibuprofen or dexamethasone before a root canal can help reduce pain afterward. It's for people with a painful, inflamed tooth nerve who haven't already taken pain medicine for it.
RawalpindiAges 18–50 - NCT05918601Recruiting
Peer support program for drug recovery support
This program offers personalized support led by trained peers for people who have used drugs in the last year. You may be able to join as a participant if you meet the language, age, and recent drug-use criteria, or apply as a peer supporter if you have medical background and pass training.
Hong KongAges Any age - NCT06959524Recruiting
Drug-coated balloon for new coronary blockages
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
Jonesboro, ArkansasAges 18 years+ - NCT06865885RecruitingPhase 4
Lowering cholesterol with inclisiran in people on many medications
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
La Jolla, CaliforniaAges 18–85 - NCT05830279Recruiting
Personalized drug choices to better manage cancer treatment side effects
This trial tests a personalized approach to selecting drugs during cancer treatment. The goal is to improve how well your prescribed medicines work for symptoms and side effects while keeping you safe.
London, OntarioAges 18 years+ - NCT06757140RecruitingPhase 1/Phase 2
Opioid and sedative-like drug interaction study
This study explores how opioids and sedative-like drugs interact in the body. It aims to understand their combined effects, which could help improve safety for people who use these drugs.
Lexington, KentuckyAges 18–55 - NCT06693960RecruitingEarly Phase 1
Oregano and drug interaction study
This study looks at how oregano affects the way your body processes certain medications. It might help patients understand if oregano can change how drugs work.
Spokane, WashingtonAges 18–64 - NCT06677970RecruitingPhase 3
Blood Pressure Control After Stroke Thrombectomy
This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.
Seoul, SeoulAges 20 years+ - NCT06612775RecruitingPhase 2
Testing CB03-154 for adults with focal epilepsy
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
Melbourne, VictoriaAges 18–70 - NCT06590428Recruiting
Tracking linezolid levels for rifampin-resistant TB treatment
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
East London, Eastern CapeAges 18 years+ - NCT06551662Recruiting
Balloon vs. stent for split artery blockages
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
MilanAges 18 years+ - NCT06545292Recruiting
Blood monitoring for cancer drugs using a finger prick
This study tests an easier way to measure the amount of cancer medicine in your blood using a simple finger prick instead of a standard blood draw. If you are taking one of the listed oral or IV cancer drugs, you may be able to participate.
Leiden, South HollandAges 18–90 - NCT06448637Recruiting
Drug balloon vs. medicated stent for large heart arteries
This study compares two treatments for new blockages in large heart arteries: a drug-coated balloon (a balloon that releases medicine) versus a drug-coated stent (a small mesh tube). The goal is to see which one better helps the artery stay open and function normally.
BarcelonaAges 18 years+ - NCT06037564Enrolling by invitationPhase 4
Switching HIV treatment to a simpler daily pill
This study tests whether switching your current HIV medication to a daily pill with doravirine, dolutegravir, and lamivudine is safe and effective. It is for people whose HIV is well-controlled but who have had to change treatment before because it stopped working.
Aarau, Canton of AargauAges 18 years+ - NCT04659343Recruiting
Testing tumor care planning for metastatic kidney cancer
This trial studies a way to plan and manage care for people with metastatic renal cell carcinoma (kidney cancer that has spread). It may help doctors coordinate treatment more effectively to improve outcomes.
Aarhus, DanmarkAges 18 years+ - NCT07878104Recruiting
Ketogenic diet for hard-to-control seizures in adults
This study looks at whether a special high-fat, low-carbohydrate diet can help reduce seizures in adults whose epilepsy has not improved with two or more medications. It is an observational study, meaning participants follow the diet as part of their regular care and the research team tracks their progress.
StockholmAges 18 years+ - NCT04674969Recruiting
Register patients receiving a drug-eluting device for leg arteries
This study is a real-world registry that follows adults who receive a drug-eluting device for narrowed or blocked blood vessels in the legs (peripheral vasculature). It helps researchers understand how these devices perform in everyday care.
Jonesboro, ArkansasAges 18 years+ - NCT03745339Recruiting
Smell-based memory task in people with opioid-use disorder
This study tests how people learn and infer what something means using a smell-and-memory task. It compares people with opioid-use disorder who are abstinent, those in maintenance treatment, and healthy controls to see what affects learning and decision-making after opioid use.
Baltimore, MarylandAges 21–60 - NCT07764718Recruiting
Brain stimulation for adults with drug-resistant epilepsy
This trial tests a new type of brain stimulation to find and treat the area causing seizures in adults whose seizures don't improve with medication. It is done during a standard monitoring procedure to help doctors better target treatment.
Durham, North CarolinaAges 18 years+ - NCT03625739Recruiting
Study how TB medicines move through children’s bodies
This study looks at how common TB medicines are absorbed, used, and cleared in children who are already taking treatment for tuberculosis. It may help doctors choose safer and more effective doses for children.
BeijingAges 1 day–18 years
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.